Ammassari, A, Antinori, A, Aloisi, MS, et al (2004) Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45: 394–402.
Antinori, A, Arendt, G, Becker, JT, et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69: 1789–99.
Antiretroviral Therapy Cohort Collaboration (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet, 372: 293–9.
Barber, TJ, Bansi, L, Pozniak, A, et al (2017) Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: the MSM Neurocog Study. International Journal of STD & AIDS, 28: 715–22.
Becker, JT, Martinson, JJ, Penugonda, S, et al (2015) No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death. Journal of Neurovirology, 21: 24–31.
Blank, MB, Himelhoch, S, Walkup, J, et al (2013) Treatment considerations for HIV-infected individuals with severe mental illness. Current HIV/AIDS Reports, 10: 371–9.
Bower, JE, Ganz, PA, Aziz, N, et al (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64: 604–11.
Brew, BJ, Pemberton, L, Cunningham, P, et al (1997) Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. Journal of Infectious Diseases, 175: 963–6.
Brogan, K, Lux, J (2009) Management of common psychiatric conditions in the HIV-positive population. Current HIV/AIDS Reports, 6: 108–15.
Campos, LN, Guimaraes, MD, Remien, RH (2010) Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS and Behavior, 14: 289–99.
Carrico, AW, Johnson, MO, Morin, SF, et al (2007) Correlates of suicidal ideation among HIV-positive persons. AIDS, 21: 1199–203.
Castellon, SA, Hinkin, CH & Myers, HF (2000) Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. Journal of the International Neuropsychological Society, 6: 336–47.
Catalan, J, Harding, R, Sibley, E, et al (2011) HIV infection and mental health: suicidal behaviour – systematic review. Psychology, Health & Medicine, 16: 588–611.
Chandra, PS, Desai, G & Ranjan, S (2005) HIV & psychiatric disorders. Indian Journal of Medical Research, 121: 451–67.
Childs, EA, Lyles, RH, Selnes, OA, et al (1999) Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52: 607–13.
Clucas, C, Sibley, E, Harding, R, et al (2011) A systematic review of interventions for anxiety in people with HIV. Psychology, Health & Medicine, 16: 528–47.
Cook, JA, Grey, D, Burke, J, et al (2004) Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American Journal of Public Health, 94: 1133–40.
Crepaz, N, Passin, WF, Herbst, JH, et al (2008) Meta-analysis of cognitive-behavioral interventions on HIV-positive persons' mental health and immune functioning. Health Psychology, 27: 4–14.
Cysique, LA, Vaida, F, Letendre, S, et al (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73: 342–8.
De Hert, M, Cohen, D, Bobes, J, et al (2011) Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry, 10: 138–51.
De Ronchi, D, Bellini, F, Cremante, G, et al (2006) Psychopathology of first-episode psychosis in HIV-positive persons in comparison to first-episode schizophrenia: a neglected issue. AIDS Care, 18: 872–8.
De Sousa Gurgel, W, Da Silva Carneiro, AH, Barreto Reboucas, D, et al (2013) Prevalence of bipolar disorder in a HIV-infected outpatient population. AIDS Care, 25: 1499–503.
DeLorenze, GN, Satre, DD, Quesenberry, CP, et al (2010) Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care and STDs, 24: 705–12.
Detels, R, Muñoz, A, Mcfarlane, G, et al (1998) Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA, 280: 1497–503.
Dolder, CR, Patterson, TL, Jeste, DV (2004) HIV, psychosis and aging: past, present and future. AIDS, 18 (suppl 1): S35–42.
Dube, B, Benton, T, Cruess, DG, et al (2005) Neuropsychiatric manifestations of HIV infection and AIDS. Journal of Psychiatry & Neuroscience, 30: 237–46.
Dufour, CA, Marquine, MJ, Fazeli, PL, et al (2013) Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. Journal of Neurovirology, 19: 410–7.
Fialho, RM, Pereira, M, Mendonca, N, et al (2013) Depressive symptoms and neurocognitive performance among HIV-infected women. Women & Health, 53: 117–34.
Fillipas, S, Oldmeadow, LB, Bailey, MJ, et al (2006) A six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial. Australian Journal of Physiotherapy, 52: 185–90.
Frazer, IH, Mackay, IR, Crapper, RM, et al (1986) Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years. Quarterly Journal of Medicine, 61: 921–33.
Freudenreich, O, Goforth, HW, Cozza, KL, et al (2010) Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices. Psychosomatics, 51: 480–8.
Fu, L, Wu, MB, Hu, Y (2014) Influence of cognitive behavioural therapy on depression, medication adherence and quality of life in people living with HIV/AIDS (PLHIV): a systematic review. Chinese Journal of Evidence-Based Medicine, 14: 734–42.
Gonzalez, JS, Batchelder, AW, Psaros, C, et al (2011) Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 58: 181–7.
Gottesman, II, Groome, CS (1997) HIV/AIDS risks as a consequence of schizophrenia. Schizophrenia Bulletin, 23: 675–84.
Hanrahan, NP, Wu, E, Kelly, D, et al (2011) Randomized clinical trial of the effectiveness of a home-based advanced practice psychiatric nurse intervention: outcomes for individuals with serious mental illness and HIV. Nursing Research and Practice, .
Harris, MJ, Jeste, DV, Gleghorn, A, et al (1991) New-onset psychosis in HIV-infected patients. Journal of Clinical Psychiatry, 52: 369–76.
Heaton, RK, Clifford, DB, Franklin, DR Jr, et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75: 2087–96.
Heaton, RK, Franklin, DR, Ellis, RJ, et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Journal of Neurovirology, 17: 3–16.
Heyn, P, Abreu, BC, Ottenbacher, KJ (2004) The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Archives of Physical Medicine and Rehabilitation, 85: 1694–704.
Himelhoch, S & Medoff, DR (2005) Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care and STDs, 19: 813–22.
Himelhoch, S, Powe, NR, Breakey, W, et al (2007a) Schizophrenia, AIDS and the decision to prescribe HAART: results of a national survey of HIV clinicians. Journal of Prevention & Intervention in the Community, 33: 109–20.
Himelhoch, S, Medoff, DR & Oyeniyi, G (2007b) Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis. AIDS Patient Care and STDs, 21: 732–9.
Hinkin, CH, Castellon, SA, Atkinson, JH, et al (2001) Neuropsychiatric aspects of HIV infection among older adults. Journal of Clinical Epidemiology, 54 (suppl 1): S44–52.
Hinkin, CH, Hardy, DJ, Mason, KI, et al (2004) Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS, 18 (suppl 1): S19–25.
Ho, RC, Ho, EC, Tan, CH, et al (2009a) Pulmonary hypertension in first episode infective endocarditis among intravenous buprenorphine users: case report. American Journal of Drug and Alcohol Abuse, 35: 199–202.
Ho, RC, Ho, EC, Mak, A (2009b) Cutaneous complications among i.v. buprenorphine users. Journal of Dermatology, 36: 22–9.
Ho, RC, Ong, H, Thiaghu, C, et al (2016) Genetic variants that are associated with neuropsychiatric systemic lupus erythematosus. Journal of Rheumatology, 43: 541–51.
Honagodu, AR, Krishna, M, Sundarachar, R, et al (2013) Group psychotherapies for depression in persons with HIV: a systematic review. Indian Journal of Psychiatry, 55: 323–30.
Honn, V, Para, M, Whitacre, C, et al (1999) Effect of exercise on neuropsychological performance in asymptomatic HIV infection. AIDS and Behavior, 3: 67–74.
Horvath, KJ, Alemu, D, Danh, T, et al (2016) Creating effective mobile phone apps to optimize antiretroviral therapy adherence: perspectives from stimulant-using HIV-positive men who have sex with men. JMIR mHealth uHealth, 4: e48.
Hriso, E, Kuhn, T, Masdeu, JC, et al (1991) Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. American Journal of Psychiatry, 148: 1558–61.
Ickovics, JR, Hamburger, ME, Vlahov, D, et al (2001) Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA, 285: 1466–74.
Jefferies, K, Agrawal, N (2009) Early-onset dementia. Advances in Psychiatric Treatment, 15: 380–8.
Lake, S, Kerr, T, Buxton, J, et al (2016) Prescription opioid injection among HIV-positive people who inject drugs in a Canadian setting. AIDS and Behavior, 20: 2941–9.
Leserman, J, Pence, BW, Whetten, K, et al (2007) Relation of lifetime trauma and depressive symptoms to mortality in HIV. American Journal of Psychiatry, 164: 1707–13.
Letendre, SL, Mccutchan, JA, Childers, ME, et al (2004) Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology, 56: 416–23.
Levy, JA (1993) Pathogenesis of human immunodeficiency virus infection. Microbiological Reviews, 57: 183–289.
Lima, VD, Geller, J, Bangsberg, DR, et al (2007) The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS, 21: 1175–83.
Liu, Y, Ho, RC, Mak, A (2012a) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. Journal of Affective Disorders, 139: 230–9.
Liu, Y, Ho, RC & Mak, A (2012b) The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis. International Journal of Rheumatic Diseases, 15: 183–7.
Mak, KK, Kong, WY, Mak, A, et al (2013) Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 84: 322–8.
Maki, PM, Martin-Thormeyer, E (2009) HIV, cognition and women. Neuropsychology Review, 19: 204–14.
Malta, M, Strathdee, SA, Magnanini, MM, et al (2008) Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction, 103: 1242–57.
Mayston, R, Patel, V, Abas, M, et al (2015) Determinants of common mental disorder, alcohol use disorder and cognitive morbidity among people coming for HIV testing in Goa, India. Tropical Medicine and International Health, 20: 397–406.
McLean, CP, Fitzgerald, H (2016) Treating posttraumatic stress symptoms among people living with HIV: a critical review of intervention trials. Current Psychiatry Reports, 18: 83.
Miller, AK, Lee, BL, Henderson, CE (2012) Death anxiety in persons with HIV/AIDS: a systematic review and meta-analysis. Death Studies, 36: 640–63.
Modipane, MB, Waldman, AL, Ritterband, L, et al (2016) Technology use among patients in a nonurban southern U.S. HIV clinic in 2015. Telemedicine and e-Health, 22: 965–8.
Moore, RD, Chaisson, RE (1999) Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS, 13: 1933–42.
Morgan, EE, Weber, E, Rooney, AS, et al (2012) Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND). Journal of Clinical and Experimental Neuropsychology, 34: 416–27.
Muniyandi, K, Venkatesan, J, Arutselvi, T, et al (2012) Study to assess the prevalence, nature and extent of cognitive impairment in people living with AIDS. Indian Journal of Psychiatry, 54: 149–53.
Muñoz-Moreno, JA, Fumaz, CR, Ferrer, MJ, et al (2008) Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Research and Human Retroviruses, 24: 1301–7.
Murray, KJ, Cummins, D, Batterham, M, et al (2016) Does the informal caregiver notice HIV associated mild cognitive impairment in people living with HIV?
AIDS Care, 28: 221–7.
Nigam, S, Mitra, D & Lahue, BJ (2014) A systematic review of the effectiveness of health information technology interventions in improving medication adherence. Value in Health, 17: A162–3.
O'Brien, KK, Tynan, AM, Nixon, SA, et al (2016) Effectiveness of aerobic exercise for adults living with HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol. BMC Infectious Diseases, 16: 182.
Owe-Larsson, B, Sall, L, Salamon, E, et al (2009) HIV infection and psychiatric illness. African Journal of Psychiatry, 12: 115–28.
Palepu, A, Horton, NJ, Tibbetts, N, et al (2004) Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction, 99: 361–8.
Pereda, M, Ayuso-Mateos, JL, Gomez Del Barrio, A, et al (2000) Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychological Medicine, 30: 205–17.
Pirraglia, PA, Bishop, D, Herman, DS, et al (2005) Caregiver burden and depression among informal caregivers of HIV-infected individuals. Journal of General Internal Medicine, 20: 510–4.
Puri, BK, Hall, A, Ho, R (2014) Revision Notes in Psychiatry (3rd edn). CRC Press.
Remien, RH, Stirratt, MJ, Dolezal, C, et al (2005) Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS, 19: 807–14.
Richardson, MA, Morgan, EE, Vielhauer, MJ, et al (2005) Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample. AIDS Care, 17: 1013–21.
Rivera-Rivera, Y, Vazquez-Santiago, FJ, Albino, E, et al (2016) Impact of depression and inflammation on the progression of HIV disease. Journal of Clinical & Cellular Immunology, 7: 423
Robertson, KR, Smurzynski, M, Parsons, TD, et al (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21: 1915–21.
Sacktor, N, Lyles, RH, Skolasky, R, et al (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology, 56: 257–60.
Saing, T, Valdivia, A, Hussain, P, et al (2016) Data on pro-inflammatory cytokines IL-1beta, IL-17, and IL-6 in the peripheral blood of HIV-infected individuals. Data Brief, 8: 1044–7.
Sallim, AB, Sayampanathan, AA, Cuttilan, A, et al (2015) Prevalence of mental health disorders among caregivers of patients with Alzheimer disease. Journal of the American Medical Directors Association, 16: 1034–41.
Sambamoorthi, U, Walkup, J, Olfson, M, et al (2000) Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression. Journal of General Internal Medicine, 15: 311–20.
Samet, JH, Horton, NJ, Traphagen, ET, et al (2003) Alcohol consumption and HIV disease progression: are they related?
Alcoholism: Clinical and Experimental Research, 27: 862–7.
Samet, JH, Horton, NJ, Meli, S, et al (2004) Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcoholism: Clinical and Experimental Research, 28: 572–7.
Sarkar, S, Subramaniam, E, Konthoujam, J (2016) A novel approach in the detoxification of intravenous buprenorphine dependence. Indian Journal of Psychiatry, 58: 152–6.
Schechter, MT, Boyko, WJ, Craib, KJ, et al (1987) Effects of long-term seropositivity to human immunodeficiency virus in a cohort of homosexual men. AIDS, 1: 77–82.
Schumacher, JE, Mccullumsmith, C, Mugavero, MJ, et al (2013) Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment. AIDS and Behavior, 17: 2781–91.
Scott-Sheldon, LA, Kalichman, SC, Carey, MP, et al (2008) Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychology, 27: 129–39.
Sevigny, JJ, Albert, SM, McDermott, MP, et al (2004) Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology, 63: 2084–90.
Sevigny, JJ, Albert, SM, McDermott, MP, et al (2007) An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Archives of Neurology, 64: 97–102.
Sewell, DD, Jeste, DV, Atkinson, JH, et al (1994) HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group. American Journal of Psychiatry, 151: 237–42.
Shedlack, KJ, Soldato-Couture, C, Swanson, CL Jr (1994) Rapidly progressive tardive dyskinesia in AIDS. Biological Psychiatry, 35: 147–8.
Sherr, L, Clucas, C, Harding, R, et al (2011) HIV and depression – a systematic review of interventions. Psychology, Health & Medicine, 16: 493–527.
Shiramizu, B, Gartner, S, Williams, A, et al (2005) Circulating proviral HIV DNA and HIV-associated dementia. AIDS, 19: 45–52.
Sin, NL, Dimatteo, MR (2014) Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Annals of Behavioral Medicine, 47: 259–69.
Singh, D, Goodkin, K (2007) Psychopharmacologic treatment response of HIV-infected patients to antipsychotic medications. Journal of Clinical Psychiatry, 68: 631–2.
Spies, G, Asmal, L, Seedat, S (2013) Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic review. Journal of Affective Disorders, 150: 171–80.
Sullivan, LE, Tetrault, J, Bangalore, D, et al (2006) Training HIV physicians to prescribe buprenorphine for opioid dependence. Substance Abuse, 27: 13–8.
Tate, D, Paul, RH, Flanigan, TP, et al (2003) The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care and STDs, 17: 115–20.
Tozzi, V, Balestra, P, Bellagamba, R, et al (2007) Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes, 45: 174–82.
UNAIDS (2007) 2007 AIDS Epidemic Update: December 2007.
UNAIDS (2016) Global AIDS Update: 2016.
Uthman, OA, Magidson, JF, Safren, SA, et al (2014) Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Current HIV/AIDS Reports, 11: 291–307.
Valcour, VG, Shiramizu, BT, Sithinamsuwan, P, et al (2009) HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study. Neurology, 72: 992–8.
Woods, SP, Carey, CL, Moran, LM, et al (2007) Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Archives of Clinical Neuropsychology, 22: 187–95.
World Health Organization (2007) WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunologial Classification of HIV-Related Disease in Adults and Children.
Yang, Y, Liu, Y-H, Zhang, H-F, et al (2015) Effectiveness of mindfulness-based stress reduction and mindfulness-based cognitive therapies on people living with HIV: a systematic review and meta-analysis. International Journal of Nursing Sciences, 2: 283–94.
Yehia, BR, Cui, W, Thompson, WW, et al (2014) HIV testing among adults with mental illness in the United States. AIDS Patient Care and STDs, 28: 628–34.
Zhang, MWB, Ho, CSH, Cheok, CCS, et al (2015) Smartphone apps in mental healthcare: the state of the art and potential developments. BJPsych Advances, 21: 354–8.
Zogg, JB, Woods, SP, Weber, E, et al (2010) HIV-associated prospective memory impairment in the laboratory predicts failures on a semi-naturalistic measure of health care compliance. Clinical Neuropsychology, 24: 945–62.